Boditech Med Inc
KOSDAQ:206640
Intrinsic Value
Boditech Med, Inc. engages in the provision of in-vitro diagnostics analyzers and reagents. [ Read More ]
The intrinsic value of one Boditech Med Inc stock under the Base Case scenario is hidden KRW. Compared to the current market price of 16 940 KRW, Boditech Med Inc is hidden .
Valuation Backtest
Boditech Med Inc
Run backtest to discover the historical profit from buying and selling Boditech Med Inc stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Boditech Med Inc
Current Assets | 138.7B |
Cash & Short-Term Investments | 76.2B |
Receivables | 28.6B |
Other Current Assets | 33.9B |
Non-Current Assets | 89.2B |
Long-Term Investments | 21.8B |
PP&E | 56.4B |
Intangibles | 5.5B |
Other Non-Current Assets | 5.4B |
Current Liabilities | 27.3B |
Accounts Payable | 5.2B |
Accrued Liabilities | 5.5B |
Short-Term Debt | 7.1B |
Other Current Liabilities | 9.4B |
Non-Current Liabilities | 14.4B |
Long-Term Debt | 2.7B |
Other Non-Current Liabilities | 11.8B |
Earnings Waterfall
Boditech Med Inc
Revenue
|
134.2B
KRW
|
Cost of Revenue
|
-53.3B
KRW
|
Gross Profit
|
80.9B
KRW
|
Operating Expenses
|
-52.4B
KRW
|
Operating Income
|
28.5B
KRW
|
Other Expenses
|
-2.5B
KRW
|
Net Income
|
25.9B
KRW
|
Free Cash Flow Analysis
Boditech Med Inc
Profitability Score
Profitability Due Diligence
Boditech Med Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.
Score
Boditech Med Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Boditech Med Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.
Score
Boditech Med Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Boditech Med Inc
According to Wall Street analysts, the average 1-year price target for Boditech Med Inc is 22 000 KRW .
Shareholder Return
Price
Boditech Med Inc
Average Annual Return | 19.41% |
Standard Deviation of Annual Returns | 91.6% |
Max Drawdown | -77% |
Market Capitalization | 372.2B KRW |
Shares Outstanding | 21 968 836 |
Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Boditech Med, Inc. engages in the provision of in-vitro diagnostics analyzers and reagents. The company is headquartered in Chuncheon, Gangwon-Do. The company went IPO on 2014-12-29. The firm is engaged in the manufacture and sale of antigen diagnostic kits and other products. In addition, the Company is engaged in the manufacture and sale of cancer diagnostic kit, drug concentration diagnostic kit and other products. The firm sells its products within domestic market and to overseas markets. The firm was established in 1998 and is located in Chuncheon-si, Gang-won-do, South Korea.
Contact
IPO
Employees
Officers
The intrinsic value of one Boditech Med Inc stock under the Base Case scenario is hidden KRW.
Compared to the current market price of 16 940 KRW, Boditech Med Inc is hidden .